- Events & ActivityEvents & Activity
- Immuno-Oncology Summit Europe 2017
- Hardman Research: SCIB development update
- Holding(s) in Company
- Interim Results
- Partnership to Advance Lung Cancer Clinical Trials
- Research Update - Amendment
- Research Update
- World Immunotherapy Congress and Biotech and Money
- Results of AGM
- Preparing SCIB2 for clinical study in lung cancer
Scancell Holdings PLC (SCLP:LSE) closed at 14.38, 12.30% above the 52 week low of 12.80 set on Jun 24, 2016.
12.80Jun 24 201621.36Jun 10 2016
|Market cap||37.60m GBP|
|EPS (TTM)||-0.0127 GBP|
Data delayed at least 20 minutes, as of Mar 27 2017 13:57 BST.